The ACP has published 'weak' guidelines for screening patients for kidney disease based on limited or no data, which could harm patients with undiagnosed or progressive kidney disease. As kidney experts weren't involved in the development of these guidelines, what should all health professionals know about screening for kidney disease?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The screening for chronic kidney disease among older people across Europe (SCOPE) project: findings from cross-sectional analysis
BMC Geriatrics Open Access 02 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Qaseem, A., Hopkins, R., Sweet, D. E., Starkey, M. & Shekelle, P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the Clinical Guidelines Committee of the American College of Physicians. Ann. Intern. Med. http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00726.
American Society of Nephrology. ASN emphasizes need for early detection of kidney disease, a silent killer [online], (2013).
Susantitaphong, P. et al. World incidence of AKI: a meta-analysis. Clin. J. Am. Soc. Nephrol. 8, 1482–1493 (2013).
Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors—United States, 1999–2004. MMWR Morb. Mortal. Wkly Rep. 56, 161–165 (2007).
United States Renal Data System. 2012 USRDS Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States [online], (2012).
Murray, C. J. & Lopez, A. D. Measuring the global burden of disease. N. Engl. J. Med. 369, 448–457 (2013).
American Academy of Family Clinicians. Screening chronic kidney disease [online], (2012).
Moyer, V. A. et al. Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 157, 567–570 (2012).
De Boer, I. H. et al. Screening for chronic kidney disease. Ann. Intern. Med. 158, 362–363 (2013).
Qaseem, A. et al. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann. Intern. Med. 153, 194–199 (2010).
Acknowledgements
This article reflects the opinions of Bruce A. Molitoris, past president of the American Society of Nephrology (ASN). The ASN is currently drafting a more-comprehensive response to the American College of Physicians' guidelines on screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author is a FAST BioMedical founder, patent owner, partial owner and medical director.
Rights and permissions
About this article
Cite this article
Molitoris, B. Screening for kidney disease—a lost opportunity. Nat Rev Nephrol 10, 6–8 (2014). https://doi.org/10.1038/nrneph.2013.258
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.258